This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
3 days in-person. 3 days virtually.
March 20–22, 2023 | Basel, SwitzerlandMarch 28–30, 2023 | Digital

Belyntic GmbH


In recent years, humanity has seen which health threats viral diseases can pose to life. At the same time, our bodies are equipped with a powerful network that needs to be unleashed to successfully overcome such threats. At Belyntic, we develop T-cell immunotherapies against diseases with significant unmet medical needs based on self-adjuvant peptide vaccines. We are about to start the preclinical development of our first vaccine candidate against PML, a rare but fatal neurodegenerative disease.